|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 1 73-83, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
MS Pepper, N Ferrara, L Orci and R Montesano
Department of Morphology, University Medical Center, Geneva, Switzerland.
Using an in vitro model in which endothelial cells can be induced to invade a three-dimensional collagen gel to form capillary-like tubular structures, we demonstrate that leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. The inhibitory effect was observed on both bovine aortic endothelial (BAE) and bovine microvascular endothelial (BME) cell, and occurred irrespective of the angiogenic stimulus, which included basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), the synergistic effect of the two in combination, or the tumor promoter phorbol myristate acetate. LIF inhibited bFGF- and VEGF-induced proliferation in BAE and BME cells. In addition, LIF inhibited BAE but not BME cell migration in a conventional two-dimensional assay. Finally, LIF decreased the proteolytic activity of BAE and BME cells and increased their expression of plasminogen activator inhibitor-1. These results demonstrate that LIF inhibits angiogenesis in vitro, an effect that can be correlated with a LIF-mediated decrease in endothelial cell proliferation, migration and extracellular proteolysis.
This article has been cited by other articles:
|
|
 |
|
  A. Ueda, M. Koga, M. Ikeda, S. Kudo, and K. Tanishita Effect of shear stress on microvessel network formation of endothelial cells with in vitro three-dimensional model Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H994 - H1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Rolfe, S. Stamatiou, C. J. World, L. Brown, A. C. Thomas, J. A. Bingley, N. F. Worth, and J. H. Campbell Leukaemia inhibitory factor retards the progression of atherosclerosis Cardiovasc Res, April 1, 2003; 58(1): 222 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. A. Sherwin, S. K. Smith, A. Wilson, and A. M. Sharkey Soluble gp130 is Up-Regulated in the Implantation Window and Shows Altered Secretion in Patients with Primary Unexplained Infertility J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3953 - 3960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Tille, J. Wood, S.J. Mandriota, C. Schnell, S. Ferrari, J. Mestan, Z. Zhu, L. Witte, and M. S. Pepper Vascular Endothelial Growth Factor (VEGF) Receptor-2 Antagonists Inhibit VEGF- and Basic Fibroblast Growth Factor-Induced Angiogenesis in Vivo and in Vitro J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1073 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bader, H. Al-Dubai, and G. Weitzer Leukemia Inhibitory Factor Modulates Cardiogenesis in Embryoid Bodies in Opposite Fashions Circ. Res., April 14, 2000; 86(7): 787 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Paradis and R. Gendron LIF transduces contradictory signals on capillary outgrowth through induction of stat3 and (P41/43)MAP kinase J. Cell Sci., January 12, 2000; 113(23): 4331 - 4339. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Vasse, J. Pourtau, V. Trochon, M. Muraine, J.-P. Vannier, H. Lu, J. Soria, and C. Soria Oncostatin M Induces Angiogenesis In Vitro and In Vivo Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1835 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text]
|
|
|
|
 |
|
 A.M. Sharkey, A. King, D.E. Clark, T.D. Burrows, P.P. Jokhi, D.S. Charnock-Jones, Y.W. Loke, and S.K. Smith Localization of Leukemia Inhibitory Factor and Its Receptor in Human Placenta Throughout Pregnancy Biol Reprod, February 1, 1999; 60(2): 355 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Collo and M. Pepper Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro J. Cell Sci., January 2, 1999; 112(4): 569 - 578. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Lee, I. Struman, C. Clapp, J. Martial, and R. I. Weiner Inhibition of Urokinase Activity by the Antiangiogenic Factor 16K Prolactin: Activation of Plasminogen Activator Inhibitor 1 Expression Endocrinology, September 1, 1998; 139(9): 3696 - 3703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mandriota and M. Pepper Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor J. Cell Sci., January 9, 1997; 110(18): 2293 - 2302. [Abstract] [PDF]
|
|
|
|
|
|
E. Wijelath, B Carlsen, T Cole, J Chen, S Kothari, and W. Hammond Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology J. Cell Sci., January 4, 1997; 110(7): 871 - 879. [Abstract] [PDF]
|
|
|
|
 |
|
 S. J. Mandriota, P.-A. Menoud, and M. S. Pepper Transforming Growth Factor beta1 Down-regulates Vascular Endothelial Growth Factor Receptor 2/flk-1 Expression in Vascular Endothelial Cells J. Biol. Chem., May 10, 1996; 271(19): 11500 - 11505. [Abstract] [Full Text] [PDF]
|
|
